The first patient has been enrolled in a four-year, 120-person study of the rate of disease progression and severity in people with mutations in the USH2A gene, a mutation that causes blindness and in some cases the loss of both vision and hearing. Additional information is available here.
News from NORD
Foundation Fighting Blindness Opens USH2A Natural History Study
Publish date: September 27, 2017
![](/sites/all/themes/custom/medstat_aurora/img/consolidated-logos/medstat_oncr/logo.png)